-- EUROPE RESEARCH ROUNDUP-GlaxoSmithKline, Gjensidige, ASML Holding 
-- 
-- Thu Apr 17, 2014 02:16AM EDT
-- None



April 17 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Gjensidige and GlaxoSmithKline, on Thursday.

HIGHLIGHTS * Gjensidige <GJFS.OL>: JP Morgan cuts to underweight from neutral * GlaxoSmithKline PLC <GSK.L>: UBS cuts target price to 1500p from 1650p; rating neutralFollowing is a summary of research actions on European companies reported by Reuters on Thursday. Stock entries are in alphabetical order. See bottom of the table for sector changes.* ASML Holding NV <ASML.AS>: Jefferies cuts target to 75 euros from 80 euros; rating buy  * Gjensidige <GJFS.OL>: JP Morgan cuts to underweight from neutral * Gjensidige <GJFS.OL>: JP Morgan cuts  target price to Nok 103.80 from Nok 104.30  * GlaxoSmithKline PLC <GSK.L>: UBS cuts target price to 1500p from 1650p; rating neutral * Kuehne & Nagel <KNIN.VX>: JP Morgan cuts to underweight from neutral * Kuehne & Nagel <KNIN.VX>: JP Morgan cuts target to Sfr 108 from Sfr 115 * Regenersis PLC <RGS.L>: Panmure raises target price to 502p from 425p; rating buy * Sampo <SAMAS.HE>: JP Morgan ups target to 41.30 euros from 39.70 euros; rating overweight * Shire PLC <SHP.L>: UBS cuts target price to 3150p from 3450p; rating neutral * Topdanmark <TOP.CO>: JP Morgan raises target to Dkk 139 from Dkk 134; rating underweight * William Hill PLC <WMH.L>: Jefferies cuts to hold from buy; target price to 350p from 500p